FDA Approves First Over-the-Counter Continuous Glucose Monitor for Diabetes Management
-
The FDA approved the first over-the-counter continuous glucose monitor (CGM), Dexcom's Stelo Glucose Biosensor System.
-
Stelo has a sensor that goes into the upper arm and pairs with a smartphone app to show blood glucose measurements every 15 minutes.
-
It's designed for adults 18+ not on insulin, like those managing diabetes with oral meds or monitoring sugar intake.
-
It gives insight into how food and activity impact health, so could help those with insulin resistance or risk of developing diabetes.
-
Stelo will be available this summer, with each sensor patch lasting 15 days before replacement; pricing not yet announced.